Usability Evaluation - Reassure Respiration Rate Device: Home User Study
NCT ID: NCT02740517
Last Updated: 2021-05-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2014-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this usability evaluation is to understand any issues that the intended user population have while using the device unsupervised in the home and to determine if the device can collect data that is of sufficient quality to be successfully analysed for respiration rate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reassure Device: Measurement Accuracy of Continuous Respiration Rate
NCT02740478
Suitability of Unobtrusive Bed Monitoring and Wrist-worn Heart Rate Monitor for Patient Monitoring
NCT03572751
Automate Detection of Sleep Apnea by ApneascanTM
NCT02045173
Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data
NCT03257189
Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients
NCT04003415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Other objectives:
* To gather useful feedback on the user interface and suggestions for its improvement.
* To gather information on the device stability in the more variable conditions of the home user environment.
* To gather data in order to demonstrate compliance with IEC62366, and thus IEC60601-1
The users had the device for a minimum of 10 nights, to confirm if the device could be used for an extended period and the likely compliance rates of users
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HUT1
First phase of the home user trial. 19 users, 12 who were part of a couple and 7 who were single.
No interventions assigned to this group
HUT2
Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1. Total 11 users.
Main change to device was a simpler set of displays and button-sequence on a 24 hour period.
No interventions assigned to this group
HUT3
Third phase of home user trial, testing the final improvements to the device. A total of 18 users, 16 of which who were part of a couple and 2 who were single.
Main change was the introduction of a scheduled recording option, making the device totally automatic in routine use.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
95 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ResMed
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Phillips, MA, MSc
Role: PRINCIPAL_INVESTIGATOR
ResMed Sensor Technologies Ltd
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D22105-115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.